Does DAROLUTAMIDE Cause Urinary retention? 24 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Urinary retention have been filed in association with DAROLUTAMIDE (NUBEQA). This represents 0.7% of all adverse event reports for DAROLUTAMIDE.
24
Reports of Urinary retention with DAROLUTAMIDE
0.7%
of all DAROLUTAMIDE reports
1
Deaths
10
Hospitalizations
How Dangerous Is Urinary retention From DAROLUTAMIDE?
Of the 24 reports, 1 (4.2%) resulted in death, 10 (41.7%) required hospitalization, and 2 (8.3%) were considered life-threatening.
Is Urinary retention Listed in the Official Label?
Yes, Urinary retention is listed as a known adverse reaction in the official FDA drug label for DAROLUTAMIDE.
What Other Side Effects Does DAROLUTAMIDE Cause?
Fatigue (384)
Death (361)
Hot flush (203)
Asthenia (173)
Prostatic specific antigen increased (156)
Off label use (133)
Neuropathy peripheral (127)
Diarrhoea (122)
Dizziness (122)
Rash (116)
What Other Drugs Cause Urinary retention?
MIRABEGRON (706)
QUETIAPINE (617)
TAMSULOSIN (475)
ADALIMUMAB (452)
MORPHINE (407)
OLANZAPINE (405)
SERTRALINE (380)
PREGABALIN (376)
RISPERIDONE (375)
DULOXETINE (362)
Which DAROLUTAMIDE Alternatives Have Lower Urinary retention Risk?
DAROLUTAMIDE vs DARUNAVIR
DAROLUTAMIDE vs DARUNAVIR ETHANOLATE
DAROLUTAMIDE vs DARUNAVIR\RITONAVIR
DAROLUTAMIDE vs DASABUVIR
DAROLUTAMIDE vs DASABUVIR\OMBITASVIR HEMINONAHYDRATE\PARITAPREVIR\RITONAVIR